Abbott Laboratories (BUE:ABT) Short Percentage of Float

View and export this data going back to . Start your Free Trial

What is Abbott Laboratories Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Abbott Laboratories's Short Percentage of Float

For the Medical Devices subindustry, Abbott Laboratories's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Abbott Laboratories's Short Percentage of Float Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Abbott Laboratories's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Abbott Laboratories's Short Percentage of Float falls into.

Abbott Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Abbott Laboratories (BUE:ABT) » Definitions » Short Percentage of Float

Comparable Companies

Traded in Other Exchanges

ABT:USA ABT:Mexico ABLd:UK ABL:Germany ABL:Germany ABL:Germany ABL:Germany ABTT34:Brazil ABL:Bulgaria ABT:Austria

Address

100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400

Website

https://www.abbottinvestor.com

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.